What is the fair value of Stevanato Group SpA (NYSE-STVN) stock?

The current fair value estimate for Stevanato Group SpA (NYSE-STVN) is $20.55. This implies an estimated upside of 7.2% versus the current market price.

Is Stevanato Group SpA (NYSE-STVN) undervalued or overvalued?

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 7.2% versus the current market price.

What is the analyst price target for NYSE-STVN stock?

The available analyst price target for Stevanato Group SpA (NYSE-STVN) is $24.45. The analyst target implies estimated upside of 27.5%.

How is the financial health of Stevanato Group SpA?

The current financial health read for Stevanato Group SpA (NYSE-STVN) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

When is Stevanato Group SpA's next earnings date?

The next earnings date currently listed for Stevanato Group SpA (NYSE-STVN) is August 11, 2026.

Does Stevanato Group SpA (NYSE-STVN) pay dividends?

Based on the current data, dividend yield is 0.3%, upcoming dividend amount is 0.06, ex-dividend date is June 11, 2026, payment date is July 29, 2026.

What is the P/E ratio for Stevanato Group SpA (NYSE-STVN)?

The current P/E ratio listed for Stevanato Group SpA (NYSE-STVN) is 32.4x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

What is the market capitalization of Stevanato Group SpA?

The current market capitalization listed for Stevanato Group SpA is 5.228 B.

What is the enterprise value of Stevanato Group SpA?

The current enterprise value listed for Stevanato Group SpA is 5.696 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

What is the ticker symbol for Stevanato Group SpA?

The ticker symbol for Stevanato Group SpA is NYSE-STVN, and the stock is listed on NYSE.

Where is Stevanato Group SpA (NYSE-STVN) listed?

Stevanato Group SpA (NYSE-STVN) is listed on NYSE.

What is the debt-to-total-capital ratio for Stevanato Group SpA?

The current debt-to-total-capital ratio listed for Stevanato Group SpA is 9.0%, which helps investors evaluate the company’s financing structure and leverage profile.

What is the free float for Stevanato Group SpA?

The free float listed for Stevanato Group SpA is 17.9%. Free float helps investors understand how much of the share base is available for public trading.

Stevanato Group SpA (STVN) Fair Value & Stock Analysis

Stevanato Group SpA (STVN)

Stevanato Group S.p.A. is an Italy-based healthcare company listed on the NYSE as common stock under the ticker STVN. The company designs, produces, and distributes products and related processes for biopharma and healthcare customers across Europe, the Middle East, Africa, North America, South America, and Asia Pacific. Its business is organized into two segments: Biopharmaceutical and Diagnostic Solutions, and Engineering.

The company’s portfolio includes drug containment products such as pre-fillable syringes, cartridges, vials, and ampoules, along with in-vitro diagnostic solutions and drug delivery systems including pen injectors, auto-injectors, and wearable injectors. It also provides diagnostic laboratory consumables, analytical and regulatory support services, medical devices, and machinery for inspection, assembly, packaging, and glass converting. In addition, Stevanato Group offers after-sales services and contract development and manufacturing for customer-owned drug delivery devices. Founded in 1949 and headquartered in Piombino Dese, Italy, the company serves pharmaceutical, biotechnology, diagnostics, and life sciences customers, and is a subsidiary of Stevanato Holding S.R.L.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Fair Value Upside/Downside	Fair Value Rating	Analyst Price Target	Analyst Target Upside/Downside	Analyst Target Rating	Overall Financial Health	Upcoming Dividend Ex-Date	Dividend Payment Date	Upcoming Dividend	Dividend Yield	Next Earnings Date	P/E Ratio	Price-to-Book Ratio	Price-to-Sales Ratio	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Payout Ratio	Free Cash Flow / Net Income
NYSE-STVN	$20.55	7.2% Upside	Fair	$24.45	27.5% Upside	Undervalued	Good	June 11, 2026	July 29, 2026	0.06	0.3%	August 11, 2026	32.4x	3.0x	3.8x	5.228 B	5.696 B	9.0%	17.9%	7.6	10.4%	1.5%